SciGenom Labs is a biotechnology startup founded in 2010 with the mission of making genomics accessible in India. Leveraging the advancements in Next-Generation sequencing technologies, the company aimed to drive down sequencing costs, potentially leading to the realization of the $1000 genome. Positioned as a service organization, SciGenom primarily offered sequencing and bioinformatics solutions to the Indian market while incubating industry-specific products in-house. The visionary founder, Sam Santhosh, believed that successful vertical solutions and products could be spun off as separate companies, leading to the formation of MedGenome and AgriGenome. As an incubator for new activities, SciGenom fosters the development of antibodies for therapeutic and reagent purposes, as well as cloning and related services. The innovative approach of incubating and nurturing new ventures within the organization sets SciGenom apart, positioning it as a potential breeding ground for future biotech successes. While pertinent details regarding the last investment and investors are not available at this time, the journey of SciGenom Labs reflects an intriguing model for incubating industry-specific solutions and products, with potential ripple effects across various verticals.
There is no investment information
No recent news or press coverage available for SciGenom Labs.